Annie Yoshiyama
Comptroller/Controller/Auditor bij ALLOGENE THERAPEUTICS, INC.
Vermogen: 254 395 $ op 31-05-2024
Profiel
Annie Yoshiyama is currently the Chief Accounting Officer, Controller & SVP at Allogene Therapeutics, Inc. She previously worked as the Chief Accounting Officer & Vice President-Finance at Tricida, Inc. from 2020 to 2023.
Prior to that, she was employed at Dolby Laboratories, Inc. as a Senior Financial Reporting from 2008 to 2018.
Annie also served as the Vice President-Finance & Controller at AN2 Therapeutics, Inc. from 2023 to 2024.
She completed her undergraduate and graduate degrees at the University of Southern California.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-06-2024 | 101 758 ( 0.05% ) | 254 395 $ | 31-05-2024 |
Actieve functies van Annie Yoshiyama
| Bedrijven | Functie | Begin |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 05-06-2024 |
Eerdere bekende functies van Annie Yoshiyama
| Bedrijven | Functie | Einde |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-03-2024 |
| TRICIDA, INC. | Comptroller/Controller/Auditor | 01-09-2023 |
| DOLBY LABORATORIES, INC. | Corporate Officer/Principal | 01-06-2018 |
Opleiding van Annie Yoshiyama
| University of Southern California | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| TRICIDA, INC. | Health Technology |
| DOLBY LABORATORIES, INC. | Technology Services |
| AN2 THERAPEUTICS, INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
